{name}
{subtitle}
Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053)
city
~23 mi. (Tucson, Arizona, +176 more cities)
facility
Arizona Oncology Associates PC- HOPE ( Site 3049)
condition
Endometrial Carcinoma, +1 more condition
drug
chemotherapy, +2 more drugs
drug type
chemotherapy, +2 more types
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)
city
~23 mi. (Tucson, Arizona, +89 more cities)
facility
Arizona Oncology Associates-Arizona Oncology ( Site 0049)
biomarker
ER Positive, +2 more biomarkers
drug
capecitabine, +4 more drugs
drug type
chemotherapy, +1 more type
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
city
~23 mi. (Tucson, Arizona, +454 more cities)
facility
University of Arizona Cancer Center-North Campus, +1 more facility
drug
brentuximab vedotin, +7 more drugs
drug type
chemotherapy, +3 more types
Sasanlimab (PF-06801591) in Combination With BCG or as Single Agent in Participants With High-Risk Non-Muscle Invasive Bladder Cancer
city
~23 mi. (Tucson, Arizona, +153 more cities)
facility
Urological Associates of Southern Arizona, P.C ., +1 more facility
condition
Bladder Urothelial Carcinoma, +2 more conditions
drug
BCG solution, +1 more drug
A Study of Chemo Only Versus Chemo Plus Nivo With or Without BMS-986205, Followed by Post- Surgery Therapy With Nivo or Nivo and BMS-986205 in Patients With MIBC
city
~23 mi. (Tucson, Arizona, +177 more cities)
facility
Arizona Oncology Associates
drug
cisplatin, +3 more drugs
drug type
chemotherapy, +1 more type
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)
city
~23 mi. (Tucson, Arizona, +130 more cities)
facility
Arizona Institute of Urology (AIU) - Northwest ( Site 1096)
drug
BCG solution, +1 more drug
Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)
city
~23 mi. (Tucson, Arizona, +199 more cities)
facility
The University of Arizona Cancer Center - North Campus ( Site 0039)